United Therapeutics (UTHR) Interest Coverage Ratio: History & Chart

United Therapeutics Corporation(UTHR)

Biotechnology · Silver Spring, MD

$494.63-2.64 (-0.53%)

Delayed quote: Sep 18, 2026, 4:00 PM EDT

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial hypertension (PAH) to lessen symptoms experienced during physical activity. Tyvaso, an inhaled form of the prostacyclin analogue treprostinil, designed to enhance exercise capacity in patients with PAH and pulmonary hypertension linked to interstitial lung disease (PH-ILD). Orenitram, a treprostinil tablet formulation, also aims to boost the exercise capabilities of PAH patients. Unituxin, a monoclonal antibody utilized in the treatment of high-risk neuroblastoma. Adcirca, an oral PDE-5 inhibitor, which helps improve exercise performance in those with PAH. United Therapeutics also maintains a robust development pipeline, including: Tyvaso DPI, a dry powder inhaler version of Tyvaso. The Remunity Pump, a compact, lightweight, and durable infusion system for treprostinil, accompanied by a separate controller. RemoPro and Ralinepag, both investigational treatments for PAH. Aurora-GT, a gene therapy product focused on regenerating blood vessels within the lungs. Clinical trials such as Tyvaso PERFECT and TETON, which are evaluating Tyvaso's efficacy in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company has forged strategic alliances and licensing agreements with various entities, such as DEKA Research & Development Corp. for a semi-disposable subcutaneous treprostinil delivery system; MannKind Corporation for the development and licensing of treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. for the development of Ralinepag. Established in 1996, United Therapeutics Corporation is headquartered in Silver Spring, Maryland.

Silver Spring, MD

1,400 employees

www.unither.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martine A. Rothblatt

View full financials

UTHR Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

77.81x

INTEREST COVERAGE RATIO AVG TTM

103.54x

INTEREST COVERAGE RATIO AVG 3Y

59.49x

INTEREST COVERAGE RATIO AVG 5Y

39.46x

INTEREST COVERAGE RATIO AVG 10Y

47.03x

INTEREST COVERAGE RATIO AVG 15Y

37.58x

INTEREST COVERAGE RATIO AVG 20Y

34.51x

CURRENT VS TTM AVG

-24.85%

CURRENT VS 3Y AVG

+30.79%

CURRENT VS 5Y AVG

+97.19%

CURRENT VS 10Y AVG

+65.46%

CURRENT VS 15Y AVG

+107.07%

CURRENT VS 20Y AVG

+125.48%

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

+1030.14%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
United Therapeutics Corporation (UTHR)	$21.00B	77.81x	103.54x	59.49x	39.46x
STERIS plc (STE)vs ›	$19.98B	18.15x	14.10x	10.28x	10.20x
Viatris Inc. (VTRS)vs ›	$19.74B	-5.65x	0.68x	1.36x	1.37x
Zimmer Biomet Holdings, Inc. (ZBH)vs ›	$18.45B	4.65x	5.28x	5.28x	4.27x
BioNTech SE (BNTX)vs ›	$24.13B	-45.74x	444.02x	1201.03x	1201.03x
Medpace Holdings, Inc. (MEDP)vs ›	$17.09B	N/A	393.08x	892.58x	554.26x
Incyte Corporation (INCY)vs ›	$25.40B	553.04x	298.73x	269.07x	276.66x
West Pharmaceutical Services, Inc. (WST)vs ›	$25.49B	1029.00x	617.01x	353.82x	258.97x
Revvity, Inc. (RVTY)vs ›	$16.00B	3.87x	4.06x	4.92x	8.88x
Labcorp Holdings Inc. (LH)vs ›	$26.30B	6.77x	5.99x	5.91x	8.30x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

United Therapeutics Corporation (UTHR)

$21.00B

77.81x

103.54x

59.49x

39.46x

STERIS plc (STE)vs ›

$19.98B

18.15x

14.10x

10.28x

10.20x

Viatris Inc. (VTRS)vs ›

$19.74B

-5.65x

0.68x

1.36x

1.37x

Zimmer Biomet Holdings, Inc. (ZBH)vs ›

$18.45B

4.65x

5.28x

4.27x

BioNTech SE (BNTX)vs ›

$24.13B

-45.74x

444.02x

1201.03x

Medpace Holdings, Inc. (MEDP)vs ›

$17.09B

N/A

393.08x

892.58x

554.26x

Incyte Corporation (INCY)vs ›

$25.40B

553.04x

298.73x

269.07x

276.66x

West Pharmaceutical Services, Inc. (WST)vs ›

$25.49B

1029.00x

617.01x

353.82x

258.97x

Revvity, Inc. (RVTY)vs ›

$16.00B

3.87x

4.06x

4.92x

8.88x

Labcorp Holdings Inc. (LH)vs ›

$26.30B

6.77x

5.99x

5.91x

8.30x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for United Therapeutics Corporation (UTHR)?

The interest coverage ratio for UTHR stock is 77.81x.

Is United Therapeutics Corporation's interest coverage ratio high or low?

The interest coverage ratio of 77.81x is 97% above its 5-year average of 39.46x, around the middle of its 5-year range (14.28x–129.77x).

What is the TTM average interest coverage ratio for United Therapeutics Corporation (UTHR)?

The TTM average interest coverage ratio for UTHR stock is 103.54x.

What is the 3Y average interest coverage ratio for United Therapeutics Corporation (UTHR)?

The 3Y average interest coverage ratio for UTHR stock is 59.49x.

What is the 5Y average interest coverage ratio for United Therapeutics Corporation (UTHR)?

The 5Y average interest coverage ratio for UTHR stock is 39.46x.

What is the 10Y average interest coverage ratio for United Therapeutics Corporation (UTHR)?

The 10Y average interest coverage ratio for UTHR stock is 47.03x.

What is the 15Y average interest coverage ratio for United Therapeutics Corporation (UTHR)?

The 15Y average interest coverage ratio for UTHR stock is 37.58x.

What is the 20Y average interest coverage ratio for United Therapeutics Corporation (UTHR)?

The 20Y average interest coverage ratio for UTHR stock is 34.51x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	114.07x
2026-03-31	108.60x
2025-12-31	115.32x
2025-09-30	129.77x
2025-06-30	49.93x
2025-03-31	62.75x
2024-12-31	45.28x
2024-09-30	33.97x
2024-06-30	27.58x
2024-03-31	26.79x
2023-12-31	17.23x
2023-09-30	20.96x
2023-06-30	21.18x
2023-03-31	20.61x
2022-12-31	14.28x
2022-09-30	34.16x
2022-06-30	32.55x
2022-03-31	61.28x
2021-12-31	36.13x
2021-09-30	49.72x
2021-06-30	47.28x
2021-03-31	-14.09x
2020-12-31	13.60x
2020-09-30	45.12x
2020-06-30	25.09x
2020-03-31	20.33x
2019-12-31	6.35x
2019-09-30	15.68x
2019-06-30	18.15x
2019-03-31	-63.68x
2018-12-31	30.58x
2018-09-30	36.49x
2018-06-30	74.97x
2018-03-31	118.04x
2017-12-31	39.71x
2017-09-30	98.12x
2017-06-30	63.21x
2017-03-31	329.50x
2016-12-31	79.18x
2016-09-30	477.20x
2016-06-30	475.33x
2016-03-31	606.17x
2015-12-31	283.99x
2015-09-30	464.12x
2015-06-30	132.49x
2015-03-31	-7.20x
2014-12-31	50.63x
2014-09-30	-6.85x
2014-06-30	37.15x
2014-03-31	46.89x
2013-12-31	-6.25x
2013-09-30	23.05x
2013-06-30	27.06x
2013-03-31	21.20x
2012-12-31	28.64x
2012-09-30	18.41x
2012-06-30	27.22x
2012-03-31	27.47x
2011-12-31	12.43x
2011-09-30	19.01x
2011-06-30	24.98x
2011-03-31	6.81x
2010-12-31	1.66x
2010-09-30	12.87x
2010-06-30	12.78x
2010-03-31	6.88x
2009-12-31	-0.60x
2009-09-30	3.52x
2009-06-30	-1.27x
2009-03-31	7.80x
2008-09-30	6.88x
2008-03-31	136.61x
2007-12-31	-246.91x
2007-09-30	19.74x
2007-06-30	11.28x
2006-12-31	7.38x
2006-06-30	11516.00x
2005-12-31	493.10x
2005-06-30	11163.00x
2004-03-31	-1186.50x
2003-12-31	-195.72x
2003-09-30	-56.23x
2002-12-31	-115.30x
2002-09-30	-261.48x

DATE

INTEREST COVERAGE RATIO

2026-06-30

114.07x

2026-03-31

108.60x

2025-12-31

115.32x

2025-09-30

129.77x

2025-06-30

49.93x

2025-03-31

62.75x

2024-12-31

45.28x

2024-09-30

33.97x

2024-06-30

27.58x

2024-03-31

26.79x

2023-12-31

17.23x

2023-09-30

20.96x

2023-06-30

21.18x

2023-03-31

20.61x

2022-12-31

14.28x

2022-09-30

34.16x

2022-06-30

32.55x

2022-03-31

61.28x

2021-12-31

36.13x

2021-09-30

49.72x

2021-06-30

47.28x

2021-03-31

-14.09x

2020-12-31

13.60x

2020-09-30

45.12x

2020-06-30

25.09x

2020-03-31

20.33x

2019-12-31

6.35x

2019-09-30

15.68x

2019-06-30

18.15x

2019-03-31

-63.68x

2018-12-31

30.58x

2018-09-30

36.49x

2018-06-30

74.97x

2018-03-31

118.04x

2017-12-31

39.71x

2017-09-30

98.12x

2017-06-30

63.21x

2017-03-31

329.50x

2016-12-31

79.18x

2016-09-30

477.20x

2016-06-30

475.33x

2016-03-31

606.17x

2015-12-31

283.99x

2015-09-30

464.12x

2015-06-30

132.49x

2015-03-31

-7.20x

2014-12-31

50.63x

2014-09-30

-6.85x

2014-06-30

37.15x

2014-03-31

46.89x

2013-12-31

-6.25x

2013-09-30

23.05x

2013-06-30

27.06x

2013-03-31

21.20x

2012-12-31

28.64x

2012-09-30

18.41x

2012-06-30

27.22x

2012-03-31

27.47x

2011-12-31

12.43x

2011-09-30

19.01x

2011-06-30

24.98x

2011-03-31

6.81x

2010-12-31

1.66x

2010-09-30

12.87x

2010-06-30

12.78x

2010-03-31

6.88x

2009-12-31

-0.60x

2009-09-30

3.52x

2009-06-30

-1.27x

2009-03-31

7.80x

2008-09-30

6.88x

2008-03-31

136.61x

2007-12-31

-246.91x

2007-09-30

19.74x

2007-06-30

11.28x

2006-12-31

7.38x

2006-06-30

11516.00x

2005-12-31

493.10x

2005-06-30

11163.00x

2004-03-31

-1186.50x

2003-12-31

-195.72x

2003-09-30

-56.23x

2002-12-31

-115.30x

2002-09-30

-261.48x

Interest Coverage Ratio: 77.81x

UTHR Interest Coverage Ratio

UTHR Average Interest Coverage Ratio Chart

UTHR Current vs Average Interest Coverage Ratio Chart

UTHR Interest Coverage Ratio Metrics

UTHR Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

UTHR Interest Coverage Ratio History

Related Metrics